InvestorsHub Logo

H2R

Followers 42
Posts 2160
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Wednesday, 10/03/2018 3:30:03 PM

Wednesday, October 03, 2018 3:30:03 PM

Post# of 4817
2018: ATRS Grand Slam

This year's events:

* Oct: Xyosted!!!
https://www.antarespharma.com/application/files/2715/3835/7488/XYOSTED_FDA_Approval_Final.pdf

* Aug: EpiPen !!!
https://www.antarespharma.com/application/files/8815/3755/0191/Vibex_Epinephrine_Auto_Injector_final-8.16.18.pdf

* Aug: Pfizer agreement!
https://www.antarespharma.com/application/files/8615/3755/0090/PFE_Final-8.6.18.pdf

* Feb: Makena/AMAG!
https://www.antarespharma.com/application/files/4315/1870/2700/Makena_Subcutaneous_Auto_Injector_Approval.pdf

I'd say ATRS is having an rather exceptional year for this industry. I believe this exceptional year will turn into commercial success starting in 2019.

Best of luck in your investment!